---
id: INT-20261030-04
date: 2026-10-30
source: Codex session, owner response to the Phase 01.1.1.2 safety and review-budget checkpoint
captured_by: Codex
context: Owner authorizes the proposed bounded escript/debugger correction and at most two additional review passes for the remaining phase PRs.
---

> Verbatim.

yes i approve

**Presented choice:** Both exact CI lanes reject a newly exposed debugger path through `escript.debug/3`, so the inventory PR cannot merge and Common Test is blocked. The project's two-review limit is exhausted. The recommended continuation is a bounded source-backed fix preserving the guard, plus at most two additional review passes, one per remaining PR.

**Authorized scope:** Resolve the bounded escript/debugger active-path failure, retain existing coverage and the active-set gate, and resume the selected phase's inventory and Common Test slices. The phase now has at most four cumulative review passes: two already used and two additional passes, one for each remaining PR. Each PR still requires unchanged checks, complete exact core/floor evidence, and a green tested-head merge. Routine continuation within this phase does not require another acknowledgment.

**Limits:** No gate weakening, blanket safe exclusion, newly banned library caller remedy, unbounded source archive expansion, target-app execution, runtime/mutation proof, next-phase execution, Macro policy, changed explanation approval, SEC-01 completion, or closure of parent verification debt is authorized by this response.
